Editorial: Therapeutic targeting of splicing variants in cancer

• Pouya Sarvari,
• Karla Rubio,
• Karla Rubio,
• Stephanie Dobersch,
• Aglaia Ntokou,
• Aglaia Ntokou,
• Verónica Vallejo-Ruiz

Affiliations

Pouya Sarvari

Independent Researcher, Puebla, Mexico

Karla Rubio

International Laboratory EPIGEN, Consejo de Ciencia y Tecnología del Estado de Puebla (CONCYTEP), Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla (BUAP), Puebla, Mexico

Karla Rubio

Laboratoire IMoPA, Université de Lorraine, CNRS, UMR 7365, Nancy, France

Stephanie Dobersch

Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, United States

Aglaia Ntokou

Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, New Haven, CT, United States

Aglaia Ntokou

Yale Department of Genetics, New Haven, CT, United States

Verónica Vallejo-Ruiz

Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla, Mexico